Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H15N2O5 |
Molecular Weight | 255.2472 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
NC(=O)C1=C[N+](=CC=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
InChI
InChIKey=JLEBZPBDRKPWTD-TURQNECASA-O
InChI=1S/C11H14N2O5/c12-10(17)6-2-1-3-13(4-6)11-9(16)8(15)7(5-14)18-11/h1-4,7-9,11,14-16H,5H2,(H-,12,17)/p+1/t7-,8-,9-,11-/m1/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4506 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27732834 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
628218
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
||
|
FDA ORPHAN DRUG |
548716
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB14933
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
PRIMARY | |||
|
100000177681
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
PRIMARY | |||
|
C158078
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
PRIMARY | |||
|
DTXSID50101003
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
PRIMARY | |||
|
439924
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
PRIMARY | |||
|
15927
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
PRIMARY | |||
|
0I8H2M0L7N
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
PRIMARY | |||
|
Nicotinamide riboside
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
PRIMARY | |||
|
1341-23-7
Created by
admin on Sat Dec 16 13:27:28 GMT 2023 , Edited by admin on Sat Dec 16 13:27:28 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)